Pfizer has helped pave the path for Americans to get a third booster dose of its mRNA COVID-19 vaccine, and the company stands to rake in billions in additional profit if the Food and Drug Administration (FDA) approves a third dose… (Excerpts from the Daily Caller)

Share

Click below to share this with others

Log in to Join the Conversation

Log in to your IFA account to start a discussion, comment, pray, and interact with our community.